在癌症治疗中利用细胞死亡和瘤免疫力:挑战和未来方向
Frontiers in cell and developmental biology
|June 18, 2024
概括
癌细胞死亡途径显著影响瘤免疫力. 了解免疫细胞死亡 (ICD) 和其他类型的细胞死亡可以导致针对瘤微环境 (TME) 的新型癌症疗法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 癌症是一个重大的全球健康挑战,发病率和死亡率不断增加.
- 瘤微环境 (TME) 在癌症进展和免疫规避中发挥着关键作用.
- 了解癌细胞死亡途径对于开发有效的抗癌策略至关重要.
研究的目的:
- 探索TME内的癌细胞死亡机制和抗瘤免疫之间的复杂关系.
- 阐明免疫细胞死亡 (ICD) 和非细胞亡细胞死亡途径在塑造免疫反应中的作用.
- 讨论利用这些途径进行新型癌症治疗的治疗策略.
主要方法:
- 对癌症负担的流行病学数据的审查.
- 深入分析免疫细胞死亡 (ICD) 和相关途径 (死,铁,烧) 的分子机制.
- 检查免疫激活中的损伤相关分子模式 (DAMP) 和瘤相关抗原 (TAA).
- 讨论针对TME的治疗影响和策略.
主要成果:
- 免疫性细胞死亡 (ICD) 诱导释放DAMP和TAA,激活树突细胞和启动T细胞进行抗瘤反应.
- 非亡性细胞死亡途径,包括亡,铁亡和热亡,有助于瘤免疫.
- 这些替代性细胞死亡模式显示出与传统疗法具有协同效应的潜力.
结论:
- 在TME中准癌症细胞死亡途径提供了有前途的治疗途径.
- 利用ICD和操纵非亡细胞死亡可以增强抗瘤免疫力.
- 进一步研究细胞死亡和瘤免疫之间的相互作用对于开发创新的癌症疗法至关重要.
关键词:
这就是ROSOS ROS.在TME中,它是最重要的.蜂信号网络是一个蜂信号网络.综合疗法 综合疗法免疫性细胞死亡 免疫性细胞死亡免疫疗法 免疫疗法细胞死亡的非亡性细胞死亡瘤微环境是一个微环境.更多相关视频
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019
22.5K
08:02In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
2.5K
相关概念视频
Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cytotoxic T Cells-mediated Immune Response
889
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
889
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
